About Us

Peptinovo Biopharma

Peptinovo Biopharma is a pre-clinical biotechnology company, founded by two experienced biotech startup entrepreneurs who have successfully created and exited from previous biotech start-ups.

Our Team

Founder Ren Homan’s insights into pharmacology, gained over 35+ years of success at both big pharma and early-stage start-ups, led to the PALM innovation.

Further, all phases necessary for a successful product launch (Chemical Manufacturing Control, FDA regulatory strategy and process, and non-clinical preclinical safety testing) are led by individuals who each have 30+ years of experience in drug development and commercial launch from preclinical testing through New Drug Application to Marketing Authorization Application.

Peptinovo Biopharma

Peptinovo Biopharma is a pre-clinical biotechnology company, founded by two experienced biotech startup entrepreneurs who have successfully created and exited from previous biotech start-ups.

Our Team

Founder Ren Homan’s insights into pharmacology, gained over 35+ years of success at both big pharma and early-stage start-ups, led to the PALM innovation.

Further, all phases necessary for a successful product launch (Chemical Manufacturing Control, FDA regulatory strategy and process, and non-clinical preclinical safety testing) are led by individuals who each have 30+ years of experience in drug development and commercial launch from preclinical testing through New Drug Application to Marketing Authorization Application.

Proven Team of Industry Experts

Dr. Ren Homan, PhD

Founder, CSO

Dr. Bill Elliott, PhD

Co-Founder, CTO

Steven Tokarz, MBA

CEO

Dr. Jan Van Tornout, MD

Chief Medical Officer

Dr. Wayne Klohs, PhD

Head of Clinical Design & Oncology Strategy

John Freshley

Corporate & Business Development

April Seiler

Program Management

Clay Cramer

Nonclinical Safety

Dr. Glenn Meyer, PhD

Product Development

Dr. David Boyd, PharmD

Clinical Operations

Jordan Pappas

Analytical Chemistry

Stephani Schlief

Biological/Biochemistry

Let’s work together to change cancer’s trajectory

We look forward to talking to you. You may contact us for more information.

Enhancing Cancer Survival Rates Through the Development of Intelligent and Targeted Drug Delivery Technologies

Contact Us

Peptinovo Biopharma Inc. 600 S Wagner Road Ann Arbor, Michigan 48103

Follow Us Social Media

Proven Team of Industry Experts

Dr. Ren Homan, PhD

Founder, CSO

Dr. Bill Elliott, PhD

Co-Founder, CTO

Steven Tokarz, MBA

CEO

Dr. Jan Van Tornout, MD

Chief Medical Officer

Dr. Wayne Klohs, PhD

Head of Clinical Design & Oncology Strategy

John Freshley

Corporate & Business Development

April Seiler

Program Management

Clay Cramer

Nonclinical Safety

Dr. Glenn Meyer, PhD

Product Development

Dr. David Boyd, PharmD

Clinical Operations

Jordan Pappas

Analytical Chemistry

Stephani Schlief

Biological/Biochemistry

Let’s work together to change cancer’s trajectory

We look forward to talking to you. You may contact us for more information.

Enhancing Cancer Survival Rates Through the Development of Intelligent and Targeted Drug Delivery Technologies

Follow Us On Social Media

Contact Us

Peptinovo Biopharma Inc. 600 S Wagner Road Ann Arbor, Michigan 48103